Recent News

• 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.09.2025 - Keros Announces Return of $375 Million in Excess Capital to Stockholders
• 06.09.2025 - Keros Announces Return of $375 Million in Excess Capital to Stockholders
• 06.06.2025 - Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
• 06.06.2025 - Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
• 05.29.2025 - Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring
• 05.29.2025 - Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring

Recent Filings

• 06.06.2025 - 8-K Current report
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - EX-99.1 EX-99.1